Virax Biolabs Group Limited (VRAX)
NASDAQ·Healthcare·Biotechnology
$0.16
+1.53%
Mkt Cap $868.39K
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
Implied Upside
+527.4%
Consensus $1.00 vs current $0.16
NASDAQ·Healthcare·Biotechnology
$0.16
+1.53%
Mkt Cap $868.39K
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$1.00
Range $1.00 – $1.00
+527.4%
Consensus $1.00 vs current $0.16